CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
CalciMedica, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.02−0.02 (-1.92%)
Close on Oct 19, 2026
- Market cap
- $17.44M
- P/E (TTM)
- –
- Dividend yield
- –
CalciMedica statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | CalciMedica | Industry median |
|---|---|---|
| Market Cap | $34.82M | $166.30M |
| Enterprise Value | $16.22M | $88.19M |
| PB Ratio | 6.32 | 2.03 |
| P/TBV Ratio | 6.32 | 2.29 |
Income (trailing twelve months)
| Measure | CalciMedica | Industry median |
|---|---|---|
| Operating Income | -$19.63M | -$21.40M |
| Net Income | -$21.24M | -$22.46M |
| EBITDA | -$19.63M | -$16.91M |
| EPS (Diluted) | -$1.35 | -$0.83 |
Returns
| Measure | CalciMedica | Industry median |
|---|---|---|
| Return on Equity (ROE) | -365.7% | -53.2% |
| Return on Assets (ROA) | -110.1% | -40.9% |
| Return on Capital Employed (ROCE) | -122.6% | -38.1% |
Balance sheet
| Measure | CalciMedica | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $18.60M | $61.43M |
| Net Cash (Debt) | $18.60M | $15.35M |
| Net Cash Per Share | $0.54 | $0.66 |
| Equity (Book Value) | $5.51M | $49.09M |
| Book Value Per Share | $0.16 | $1.37 |
| Tangible Book Value | $5.51M | $23.52M |
| Working Capital | $15.97M | $76.81M |
Financial position
| Measure | CalciMedica | Industry median |
|---|---|---|
| Current Ratio | 5.58 | 3.34 |
| Quick Ratio | 5.33 | 2.44 |
| Interest Coverage | -15.16 | -6.26 |
Cash flow (trailing twelve months)
| Measure | CalciMedica | Industry median |
|---|---|---|
| Operating Cash Flow | -$19.11M | -$12.35M |
| Capital Expenditures | -$14.00K | -$1.08M |
| Free Cash Flow | -$19.12M | -$20.22M |
| FCF Per Share | -$0.56 | -$0.42 |
Efficiency
| Measure | CalciMedica | Industry median |
|---|---|---|
| Profits Per Employee | -$1.33M | -$703.34K |
| Employee Count | 16 | 74 |
Dividends and yields
| Measure | CalciMedica | Industry median |
|---|---|---|
| Earnings Yield | -61.0% | -23.3% |
| FCF Yield | -54.9% | -8.72% |
| Buyback Yield | -34.5% | -0.59% |
| Shareholder Yield | -34.5% | 0.00% |
Shares
| Measure | CalciMedica | Industry median |
|---|---|---|
| Shares Outstanding | 34,141,500 | 58,127,000 |
| Shares Change (YoY) | 20.9% | 10.9% |
| Shares Change (QoQ) | 95.2% | 0.54% |
| Float | 14,802,500 | 49,136,700 |
| Shares Held by Insiders | 56.6% | 11.6% |
Taxes
| Measure | CalciMedica | Industry median |
|---|---|---|
| Income Tax | $0 | $79.87K |
Scores
| Measure | CalciMedica | Industry median |
|---|---|---|
| Altman Z-Score | -14.63 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from CalciMedica's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.